IRB forms and applications for continuing reviews & final reports

If approval for continuation is not granted prior to the expiration date of the protocol, all recruitment and subject enrollment must stop. Currently enrolled subjects should continue to receive treatment and follow-up that is in their best interest. Consistent failure to submit timely requests for continuing review is reportable to the FDA, OHRP, and the study sponsor.

Click here to access your study electronically in eIRB

  • Your 1st step is to open your study in eIRB, and click on the "New Continuing Review" option

A study specific Investigator Financial and Other Personal Interest Disclosure Form is required for all research personnel listed on the eIRB application when submitting a Continuing Review Form. Click on the link below to obtain an Investigator Financial and Other Personal Interest Disclosure Form.

 

Appendices for applications are located here